Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 434 entries
View as:

Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil

Phase: N/A Priority: Normal
NCT ID: NCT01897740 Org: User:
Start: - End: - Due: -

Sildenafil For Meniere's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00145483 Org: User:
Start: 06/18/02 End: 11/08/06 Due: 11/08/07

Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency

Phase: N/A Priority: Normal
NCT ID: NCT00684424 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT00647101 Org: User:
Start: 12/31/03 End: 02/28/05 Due: 02/28/06

An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01220219 Org: User:
Start: 11/30/10 End: 01/31/11 Due: 01/31/12

A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00645229 Org: User:
Start: 09/30/04 End: 03/31/05 Due: 03/31/06

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00902512 Org: User:
Start: 04/30/09 End: 04/30/09 Due: 04/30/10

A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00645515 Org: User:
Start: 06/30/03 End: 12/31/03 Due: 12/31/04

A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing

Phase: N/A Priority: Normal
NCT ID: NCT00674687 Org: User:
Start: 07/31/04 End: 06/30/06 Due: 06/30/07

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00633386 Org: User:
Start: 02/28/03 End: 08/31/03 Due: 08/31/04

A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study

Phase: N/A Priority: Normal
NCT ID: NCT00645320 Org: User:
Start: 08/31/03 End: 08/31/04 Due: 08/31/05

Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement

Phase: N/A Priority: Normal
NCT ID: NCT00648323 Org: User:
Start: 11/30/03 End: 01/31/05 Due: 01/31/06

Actual Use Trial of Atorvastatin Calcium 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT01964326 Org: User:
Start: 10/31/13 End: 12/31/14 Due: 12/31/15

Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition

Phase: N/A Priority: Normal
NCT ID: NCT01389609 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

Quality of Erection Study

Phase: N/A Priority: Normal
NCT ID: NCT00159900 Org: User:
Start: 05/31/05 End: 01/31/06 Due: 01/31/07

An Open Label Access Study For Subjects Who Completed A1481156

Phase: N/A Priority: Normal
NCT ID: NCT01582438 Org: User:
Start: - End: - Due: -

Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom

Phase: N/A Priority: Normal
NCT ID: NCT01012245 Org: User:
Start: 01/31/00 End: 12/31/08 Due: 12/31/09

Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02651623 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01191008 Org: User:
Start: 10/31/10 End: 05/31/15 Due: 05/31/16

A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01027117 Org: User:
Start: 09/30/09 End: 09/30/09 Due: 09/30/10

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

Phase: N/A Priority: Normal
NCT ID: NCT01053429 Org: User:
Start: 06/30/05 End: 02/28/10 Due: 02/28/11

Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01027689 Org: User:
Start: 04/30/11 End: 06/30/11 Due: 06/30/12

Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

Phase: N/A Priority: Normal
NCT ID: NCT00599768 Org: User:
Start: 03/31/08 End: 12/31/08 Due: 12/31/09

Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan

Phase: N/A Priority: Normal
NCT ID: NCT01989936 Org: User:
Start: 01/31/99 End: 09/30/00 Due: 09/30/01

An Open-Label Trial of Pregabalin in Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00151528 Org: User:
Start: 01/31/05 End: 06/30/06 Due: 06/30/07